Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,566 | 4,181 | 30,175 | 17,876 | 6,101 |
| Receivables | 5,483 | 5,841 | 4,238 | 3,059 | 8,760 |
| Inventories | 11,433 | 15,884 | 12,929 | 11,157 | 10,995 |
| TOTAL | $24,863 | $28,959 | $49,354 | $35,110 | $27,019 |
| Non-Current Assets | |||||
| PPE Net | 5,525 | 4,278 | 1,067 | 782 | 1,193 |
| Intangibles | 2,926 | 2,926 | 2,926 | 2,926 | 2,926 |
| Other Non-Current Assets | 1,787 | 2,023 | 1,937 | 2,207 | 709 |
| TOTAL | $10,238 | $9,227 | $5,930 | $5,915 | $4,828 |
| Total Assets | $35,101 | $38,186 | $55,284 | $41,025 | $31,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,265 | 700 | N/A | N/A | 13,466 |
| Accounts payable and accrued liabilities | 6,065 | 5,786 | 3,309 | 2,651 | 5,332 |
| Accrued Expenses | 8,881 | 9,210 | 8,276 | 6,667 | 4,744 |
| TOTAL | $19,663 | $17,807 | $13,844 | $11,223 | $25,779 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,782 | 13,091 | 13,603 | 16,186 | N/A |
| Deferred Revenues | 2,452 | 2,111 | 2,259 | 1,905 | 2,237 |
| Other Non-Current Liabilities | 1,444 | 1,981 | 2,300 | 3,214 | 1,368 |
| TOTAL | $13,482 | $15,490 | $16,232 | $19,774 | $1,726 |
| Total Liabilities | $33,145 | $33,297 | $30,076 | $30,997 | $27,505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,523 | 263 | 62 | 60 | 13 |
| Common Shares | 3 | N/A | 6 | 98 | 31 |
| Retained earnings | -316,800 | -296,168 | -267,534 | -251,376 | -234,547 |
| Other shareholders' equity | 1,650 | -733 | -623 | -385 | -701 |
| TOTAL | $1,956 | $4,889 | $25,208 | $10,028 | $4,342 |
| Total Liabilities And Equity | $35,101 | $38,186 | $55,284 | $41,025 | $31,847 |